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Background: Administrative data may be useful for epidemiological studies of chronic 
idiopathic thrombocytopenic purpura (ITP). However, the quality of the recorded diagnoses 
needs evaluation.
Aim: We evaluated the validity in predicting chronic ITP of the International Classiﬁ  cation of 
Diseases (ICD)-10 diagnoses of ITP in the Danish National Registry of Patients (NRP).
Methods: We used the NRP to identify patients with ITP, according to code D69.3, from January 1, 
1996 to December 31, 2007. We deﬁ  ned chronic ITP as lasting longer than 6 months by including 
only patients with 2 or more hospital ITP diagnoses over longer than 6 months. We conﬁ  rmed diag-
noses by evaluating each candidate chronic ITP patient’s medical chart and estimating the positive 
predictive value (PPV) and 95% conﬁ  dence interval (CI) of the recorded NRP diagnostic code.
Results: We identiﬁ  ed 513 patients with chronic ITP in the NRP. We were able to retrieve the 
charts of 439. After evaluation of the charts, 410 patients were deemed to have a valid diagnosis 
of chronic ITP, yielding a PPV of 0.93 (95% CI: 0.91–0.96).
Conclusion: The validity of this procedure to identify chronic ITP patients was high. The NRP 
is valid for epidemiological studies of patients with chronic ITP.
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Introduction
Idiopathic thrombocytopenic purpura (ITP) is a disease characterized by low platelet 
counts and bleeding complications.1 ITP patients develop autoantibodies, which cause 
premature platelet destruction and inhibit megakaryocyte production.1,2 The shortened 
lifespan of platelets in the circulation, and the incomplete compensation from increased 
platelet production by bone marrow megakaryocytes, decreases the platelet count. 
Most frequently, ITP is followed by disease remission within 6 months. However, 
approximately 25% of ITP patients have persistent, chronic disease. Some patients 
are followed as long as 30 years without remissions.3 Although chronic ITP is a com-
mon acquired bleeding disorder with potentially fatal outcomes, few data have been 
published on the epidemiology of this disease.
Medical registries, including all cases of a particular health condition or health-
related exposure, are important data sources for epidemiological and clinical research.4 
The fact that the data already exist markedly reduces the cost and the time spent on 
such studies. Another advantage is that medical databases contain information on 
large study populations, offering the potential for precise estimates of effects and for 
studying rare exposures or outcomes. At the same time, the risk of bias, such as recall 
bias and non-response, is reduced. A shortcoming is that the researchers do not control 
the data selection and quality,4,5 and that medical registries do not provide detailed 
clinical information.Clinical Epidemiology 2009:1 8
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The Danish National Registry of Patients (NRP) is a 
medical registry. The validity of diagnoses in such medical 
registries may vary. Hardly any data exist on the predictive 
quality of two or more registry-recorded ITP diagnoses over a 
period of 6 months as a measure of chronic ITP. We therefore 
estimated the validity of recorded diagnoses of chronic ITP 
in the NRP from January 1, 1996 through 2007 by comparing 
the recorded diagnoses with data from chart reviews.
Methods
We conducted this population based cohort study in Denmark, 
which has a population of about 5.4 million inhabitants. The 
entire Danish population is provided tax-supported health 
care by the National Health Service, allowing free access 
to hospital care. Specialized medical centres within public 
hospitals, operating under the auspices of the Danish National 
Health Service, provide care of all ITP patients. We used 
the unique 10-digit civil registry numbers (CPR-numbers) 
assigned to each Danish resident6 to link the national registry 
data of hospital diagnoses to the patients’ medical charts.
Using the NRP in Denmark, we identified all adult 
(aged  18 years) patients with a hospital diagnosis of ITP 
from January 1, 1996 to December 31, 2007. The NRP, 
established in 1977, covers 99.4% of all patients admitted 
to general hospitals in Denmark.7 Since 1995, all outpatient 
and emergency room visits were also included in the NRP. 
For each hospital visit, the NRP ﬁ  les include dates of admis-
sion and discharge, surgical procedure(s) performed, and up 
to 20 discharge diagnoses. Since 1994, diagnoses have been 
coded according to the 10th revision of the International Clas-
siﬁ  cation of Diseases (ICD-10).7 We identiﬁ  ed all patients 
registered with a hospital diagnosis of ITP (ICD-10 code 
D69.3). We further limited our study cohort to patients with 
chronic (lasting longer than 6 months) ITP by including only 
those with two or more hospital diagnoses of ITP over a period 
longer than 6 months.
We used the information from the chart reviews as a 
reference. In addition to requiring an ITP diagnosis recorded 
in the medical charts for a period of more than 6 months, 
we required a platelet count below 150 × 109/L without an 
obvious cause to conﬁ  rm the diagnosis. Patients who did 
not fulﬁ  l this criterion (eg, patients with secondary ITP, and 
patients who already were in remission for their ITP) were 
categorized as false positive in our study.
We estimated the positive predictive value (PPV) and 
associated 95% conﬁ  dence intervals (CI) for a diagno-
sis of chronic ITP in the NRP compared with the results 
from the medical charts. The PPV was the proportion of 
patients registered with chronic ITP in the NRP, who also 
qualiﬁ  ed as having chronic ITP according to our review of 
their charts. The numerator in this ratio was the number of 
patients registered with chronic ITP in both the NRP and 
the chart reviews, and the denominator was the number of 
patients with chronic ITP registered in the NRP. To quan-
tify how potential misclassiﬁ  cation among the patients for 
whom we were unable to retrieve the medical charts could 
affect the PPV, we repeated the analysis assuming a worst 
case scenario (ie, that all of the missing medical ﬁ  les did 
not fulﬁ  l the criteria for chronic ITP). We further estimated 
the impact of misclassiﬁ  cation on relative risk estimates, 
assuming that the Danish NRP was used to identify chronic 
ITP patients in a cohort- and a case-control design. In these 
analyses, we assumed the misclassiﬁ  cation in the chronic ITP 
diagnosis to be non-differential according to the exposure 
and outcome.
This study was approved by the Danish Data Protection 
Agency (Record no. 2007- 41-1101). The statistical software 
package SAS, version 9.1 (SAS Institute Inc., Cary, NC), 
was used for all statistical analyses.
Results
Initially, we identiﬁ  ed 2908 adult (age  18 years) patients 
registered in the NRP with a relevant ICD-10 code. Of these, 
513 (17.6%) fulﬁ  lled our deﬁ  nition of chronic ITP (ie, an 
ITP diagnosis over the course of more than 6 months). The 
remaining 2395 patients (82%) were considered to have acute 
ITP. We were able to retrieve the medical charts on 439 (86%) 
of these patients. We carefully reviewed these medical charts, 
and found that 410 patients fulﬁ  lled the criterion of a chronic 
ITP diagnosis, yielding a PPV of 0.93 (95% CI: 0.91–0.96). 
The remaining 29 patients were categorized as false positive. 
If the 74 patients, for whom we were unable to retrieve the 
medical charts, did not fulﬁ  l the criterion of a chronic ITP 
diagnosis (worst case scenario), we would have obtained a 
PPV of 0.80 (95% CI: 0.76–0.83).
Among the 439 patients, the median age at the date of 
diagnosis was 56 years (range: 18–100 years). A total of 274 
(62%) were women, and 165 (38%) were men. A total of 178 
(41%) patients were diagnosed during the ﬁ  rst 6 years of 
our study period (from 1996 through 2001), and 261 (59%) 
patients were diagnosed during the last 6 years (from 2002 
through 2007). We found no difference in PPV according to 
gender or period of diagnosis (data not shown).
To estimate the impact of misclassiﬁ  cation on relative risk 
estimates if the Danish NRP were used to identify chronic 
ITP patients in a cohort study, we simulated a study cohort Clinical Epidemiology 2009:1 9
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of 400 chronic ITP patients and 400 persons without chronic 
ITP. The chronic ITP patients and persons without chronic 
ITP were followed until death in a period of ﬁ  ve years. If 
the PPV of the chronic ITP diagnosis were 0.93, a correct 
relative risk (RR) for death (eg, mortality) among chronic 
ITP patients compared with persons without chronic ITP of 
2.00 would decline to 1.94. In a worst-case scenario, a correct 
RR of 2.00 would decline to 1.78, if the misclassiﬁ  cation of 
the chronic ITP diagnosis were 0.80. We likewise simulated 
a case-control study of 400 cases with chronic ITP and 
400 controls without chronic ITP, and estimated the odds 
ratio for chronic ITP if cases and controls had a history of 
a given exposure. A correct odds ratio (OR) of 2.11 would 
decline to 2.04, if the misclassiﬁ  cation of the chronic ITP 
diagnosis were 0.93. In a worst-case scenario, a correct OR of 
2.00 would decline to 1.88. For further details see Table 1.
Discussion
Using our procedure, comparing the data quality in the NRP 
with information obtained from chart reviews, we found that 
the predictive value of NRP diagnoses for identifying chronic 
ITP patients was 93%. This is above the accuracy of most 
validated diagnoses in the NRP.8,9
Our ﬁ  ndings suggest that the NRP can be a valuable tool 
in register-based studies, bearing in mind that the necessary 
level of data quality depends on the research question and 
design. The positive predictive value should be stable over 
time, if NRP data are used to compare the incidence of 
chronic ITP over time. We found this to be the case within 
the 12-year time-period of our study. However, we do not 
know whether there were any time trends in the data quality 
before 1996. It is important that the small misclassiﬁ  cation 
we found is unrelated to information about earlier exposures 
or future outcomes (ie, non-differential misclassiﬁ  cation), 
if NRP data are used in case-control or cohort studies. We 
expect this to be true for most exposures and outcomes. Our 
analysis, illustrating the impact of misclassiﬁ  cation on risk 
estimates if the NRP were to be used to identify chronic ITP 
patients for a cohort design or a case control design, shows 
that (under the assumption that the misclassiﬁ  cation is non-
differential according to exposure and outcome) the results 
would be biased toward conservative risk estimates. If the 
exposure had been misclassiﬁ  ed differentially according to 
chronic ITP status, or if chronic ITP patients had been mis-
classiﬁ  ed differentially according to their prognosis, the risk 
estimates would be exaggerated or underestimated.10
Table 1 The impact of misclassiﬁ  cation on various risk estimates if the Danish National Patient Registry were used to identify 
chronic ITP (cITP) patients in a cohort study and a case-control study
Correct classiﬁ  cation Positive predictive value 0.94 Positive predictive value 
0.80 (worst case scenario)
cITP yes cITP no1 cITP yes cITP no cITP yes cITP no
Cohort study
 Deaths 10 5 9.3 5 8 5
 Alive 390 395 362.7 395 320 395
 False  positive2 002 8 0 7 2 0
   Mortality rate (%) after correction 
for misclassiﬁ  cation
2.5 1.25 2.42 1.25 2.23 1.25
 RR3 2.00 1.94 1.78
Case-control study
 Exposed 40 20 37.6 20 32 20
 Controls 360 380 338.4 380 288 380
 False  positive4 002 4 0 8 0 0
   Number of exposed after correction 
for misclassiﬁ  cation
40 20 38.8 20 36 20
   Number of controls after correction 
for misclassiﬁ  cation
360 380 361.2 380 364 380
 OR5 2.11 2.04 1.88
1Misclassiﬁ  cation of the chronic ITP diagnosis will not affect the background population’s risk of chronic ITP because the disease is rare.
2The misclassiﬁ  ed patients will have the same mortality rate as the background population.
3The relative risk (RR) is independent of the study population’s size.
4The misclassiﬁ  ed patients will have the same exposure prevalence as the background population.
5The odds ratio (OR) will change towards the estimate of the RR, as the size of the study population increases.Clinical Epidemiology 2009:1 10
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Moreover, we used chart reviews for the validation of our 
procedure to identify patients with chronic ITP in the NRP, and 
we were able to estimate the PPV. Another dimension of valid-
ity is sensitivity and speciﬁ  city. The only way we could identify 
chronic ITP patients was through our procedure, and we only 
used chart reviews for the validation of diagnoses identiﬁ  ed 
through this procedure. Thus, we were unable to estimate sen-
sitivity because our design did not allow us to identify patients 
who had chronic ITP recorded in their medical charts but did 
not have chronic ITP registered in their coding. Because we did 
not know the true incidence of chronic ITP in the background 
population, we were unable to estimate speciﬁ  city.4
The diagnostic process of ITP is complex because it is, in 
large part, one of exclusion. Patients have thrombocytopenia, 
deﬁ  ned as a platelet count below 150 × 109/L without any 
obvious cause. Other causes of thrombocytopenia, such as 
disseminated intravascular coagulation, vitamin deﬁ  ciency, 
infection, and primary bone marrow disease, need to be 
considered and ruled out before the diagnosis of ITP can 
be made. Furthermore, ITP is often associated with other 
autoimmune diseases, such as systemic erythematic lupus 
(SLE), diabetes mellitus, and morbus Basedow. Therefore, 
these also need to be ruled out. It is likely that the high validity 
of our procedure for identifying chronic ITP patients in the 
NRP is due to the complex diagnostic process. Moreover, 
we only included patients with more than one admission or 
outpatient visit registered with an ITP diagnosis over a period 
longer than 6 months. Such a diagnostic procedure lowers 
the probability of a false positive ITP diagnosis. Instead, 
we may have missed some patients with chronic ITP, for 
instance, those patients who were only admitted to hospital 
with their chronic ITP once, and then referred to their general 
practitioners for future control. However, we would expect 
this to happen only for patients with a relatively high base-
line platelet count.
It is a major advantage to be able to use existing data 
sources with large amounts of information, such as the NRP, 
for research purposes. We found a high predictive value with 
our procedure for identifying chronic ITP patients in the NRP, 
suggesting that the NRP can be a valuable tool in clinical 
epidemiological studies of chronic ITP patients.
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